Diagnostics Industry

Found 5,886 articles

• Biovica Receives License for Maryland State

  12/1/2023

  Biovica International Biovica, active in cancer diagnostics, announces that the company has received a license for Maryland state, the 18th largest state in the US.

• DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy

  11/30/2023

  QIAGEN and DNA Labs International announced that DLI has recently solved two decades-old “cold cases” using QIAGEN solutions.

• Exact Sciences Presents Multiple Studies at San Antonio Breast Cancer Symposium Supporting Optimization and Individualization of Therapy for Breast Cancer Patients

  11/30/2023

  Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, will present new data and study results across its Precision Oncology and hereditary cancer platforms at the 2023 annual San Antonio Breast Cancer Symposium.

• Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration

  11/30/2023

  Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization partnership for Sysmex's Automated Immunoassay System HISCL™-Series to include the field of neurodegenerative diseases, following the discussion based on the Basic Agreement on Business Collaboration in the field of immunoassay signed in October 2023*.

• Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast

  11/29/2023

  Mainz Biomed N.V. announces that its presentation at the 35th Annual Piper Sandler Healthcare Conference, to be delivered by Chief Executive Officer, Guido Baechler and Bill Caragol, Chief Financial Officer, will be available to view live and post event via webcast by registering at the following link.

• Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)

  11/29/2023

  Company's DCA Solution Offers Robust Set of User and Medical Practitioner Features via an Android & iOS Mobile App and a Clinician Dashboard For Monitoring Patient's Cough

• Toyoda Gosei Invests in ThinkCyte, a Startup Developing Devices for the Early Detection of Leukemia and Other Diseases

  11/28/2023

  Toyoda Gosei Co., Ltd. has invested* in ThinkCyte K.K., whose technologies are used for a broad spectrum of applications, including the early detection of leukemia and other diseases, with the aim of solving social issues in the healthcare field.

• Meridian Bioscience Earns EcoVadis Bronze Medal in Recognition of Its Dedication to Sustainability

  11/28/2023

  Meridian Bioscience, Inc. has been awarded the distinguished EcoVadis Bronze Medal in recognition of the commitment to its sustainable business practices.

• Q2 Interim Report August-October 2023/2024

  11/28/2023

  Biovica International Continued sales growth and several commercial agreements signed.

• Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID

  11/27/2023

  Revvity, Inc., announced the launch of its EONIS™ Q system, a CE-IVD declared platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy and severe combined immunodeficiency in newborns.

• Asep Medical Holdings Inc. Signs Joint Venture Agreement with Leading Chinese Medical Diagnostics Company Sansure Biotech Inc.

  11/22/2023

  Asep Medical Holdings Inc. is very pleased to announce that, through its subsidiary Sepset Biosciences Inc., it has signed a definitive joint venture agreement with leading Chinese medical diagnostic company, Sansure Biotech Inc., through its subsidiary, Hunan Xiang Jiang Sansure Biotech Fund, L.P. Sansure Fund is an investment fund formed by Sansure, Changsha Sanway Spring Venture Capital CO., Ltd. and certain other investors.

• bioLytical Laboratories Inc. Donates Tests to Help Boost International Testing Access Ahead of International Testing Week

  11/22/2023

  bioLytical Laboratories Inc., a global leader in rapid in-vitro medical diagnostics and partner Coalition PLUS, a global NGO, announced that together, they have donated and distributed over 8,000 tests across 25 countries to help boost testing access worldwide.

• Biovica Receives Final Pricing Decision for DiviTum TKa Test by Medicare Effective 1st January 2024

  11/21/2023

  Biovica International Biovica, active in cancer monitoring, announces that the Center for Medicare & Medicaid Services after reviewing public comments, has agreed with the minority CDLT panel to crosswalk DiviTum TKa to reimbursement code 0058U.

• Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association

  11/20/2023

  Cardio Diagnostics Holdings, Inc., a leader in artificial intelligence-driven precision cardiovascular medicine tests, announced the publication of its groundbreaking study in the Journal of the American Heart Association, an official journal of the American Heart Association.

• Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference

  11/20/2023

  Mainz Biomed N.V. announces that Guido Baechler, Chief Executive Officer, and Bill Caragol, Chief Financial Officer, will present at the 35th Annual Piper Sandler Healthcare Conference taking place on the 28-30 November, 2023 in New York, NY, USA.

• Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States

  11/20/2023

  Universal DX announced a strategic collaboration with Quest Diagnostics, the nation's leading provider of diagnostic information services, designed to improve colorectal cancer screening in the United States – for which more than 110 million people may be eligible.

• GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of GalleriⓇ Multi-Cancer Early Detection (MCED) Test Among The Medicare Population

  11/20/2023

  GRAIL, LLC announced that it will initiate Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity following the U.S. Food and Drug Administration’s approval of GRAIL’s Investigational Device Exemption application and the Centers for Medicare and Medicaid Services’ approval for Medicare coverage of the study.

• Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

  11/20/2023

  Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced it has delivered results to one million consumers with its SneakPeek® Early Gender DNA Test.

• Volition Presents at the 5th Annual Congress of the International Liquid Biopsy Society

  11/17/2023

  VolitionRx Limited, a multi-national epigenetics company, is presenting at the 5th Annual Congress of Liquid Biopsy being held in Madrid, Spain.

• Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy

  11/17/2023

  Immunexpress, Pty Ltd. today announced a poster presentation validating the utility of SeptiCyte® RAPID in patients who are immunocompromised or are receiving immunosuppressive therapy at the Association for Molecular Pathology (AMP) 2023 Annual Meeting.